Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

CME

An Aggressive Approach to the Treatment of Acute Myocardial Infarction: Lessons from Recent Clinical Trials

This month, Richard W. Smalling, M.D., Ph.D. and Ali Denktas, M.D., discuss

CME credit is no longer available for this conference.

Course Authors

Richard W. Smalling, M.D., Ph.D. and Ali Denktas, M.D.

Dr. Denktas is a Cardiovascular Fellow, University of Texas Medical School at Houston and Hermann Hospital.

Dr. Denktas reports no commercial conflict of interest. Dr. Smalling has received grant/research support from Centocor/Boston Scientific within the last three years.

Estimated course time: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Discuss the options for acute treatment of myocardial infarction

  • List the different thrombolytics available for the treatment of acute myocardial infarction

  • Discuss the role of interventional therapy for acute myocardial infarction.

 

TERMS AND CONDITIONS

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity

Courses You Might Like

Current Management of Hypertension

The link between elevated blood pressure and cardiovascular disease is firmly established. How to treat HBP is less certain.
Authors: Aditya Khetan, M.B.B.S., Richard A Josephson, M.S., M.D. and Sri Krishna Madan Mohan M.B.B.S.
Estimated Time: 1 Hour
More

Myocardial Infarction

Significant progress has been made in the primary and secondary prevention of myocardial infarction, but it remains a leading cause of death.
Authors: Richard Josephson, M.S., M.D., and Sri K. Madan Mohan, M.D.
Estimated Time: 1 Hour
More

Management of Non-Valvular Atrial Fibrillation – The New Era of Oral Anticoagulants

The most important feature which distinguishes AF from other atrial arrhythmias is the absence of P waves.
Authors: Muhib Khan, M.D., and Karen Furie, M.D., M.P.H.
Estimated Time: 2 Hours
More

Current Management of Acute Decompensated Heart Failure

The rate of hospitalization for acute decompensated heart failure will continue to increase because of an aging population.
Authors: Joel Schilling, M.D., Ph.D.
Estimated Time: 1 Hour
More

Pharmacological Therapy of Cardiac Arrhythmias: Atrial Fibrillation, Current Treatment and Novel Agents

Cardiac arrhythmias may be seen in individuals with known cardiovascular disease (i.e., coronary artery disease (CAD) or valvular abnormalities) or even in those without known cardiac illnesses. The spectrum of cardiac arrhythmias varies between more self-limited or minimally symptomatic findings such as palpitations, which may be associated with premature supraventricular or ventricular beats that many experience, to the more worrisome ventricular fibrillation, a known cause of sudden cardiac arrest for which emergency cardiac resuscitation is required. of cardiac arrhythmias varies between more self-limited or minimally symptomatic findings such as palpitations, which may be associated with premature supraventricular or ventricular beats that many experience, to the more worrisome ventricular fibrillation, a known cause of sudden cardiac arrest for which emergency cardiac resuscitation is required.
Authors: Mohan N. Viswanathan, M.D.
Estimated Time: 1 Hour
More

Cardiac Vagal Neurostimulation for Ventricular Rate Control During Atrial Fibrillation

There are two broad strategic treatment options for AF treatment: rhythm control and rate control.
Authors: Youhua Zhang, M.D., Ph.D., and Todor N. Mazgalev, Ph.D.
Estimated Time: 1 Hour
More